Request To Download Free Sample of This Strategic Report @- https://reportocean.com/industry-verticals/sample-request?report_id=bw8527 ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8527 ...

Severe asthma and nasal polyposis: the care of patients with rhinological and respiratory disorders, in light of recent ...

Second clinical program entering Phase 2 with data expected 2026BRISBANE, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Tempest ...

Gastric Adenocarcinoma and Proximal Polyposis of the Stomach Authors : Kosuke Tanaka , M.D. , and Toshiaki Hirasawa , M.D. Author Info & Affiliations Published March 12, 2025 ...

Increase awareness about colorectal cancer to promote early diagnosis and treatment, reducing mortality rates worldwide.

Biodexa Pharmaceuticals (BDRX) is making progress in readying the launch of a phase 3 trial for eRapa, its proprietary encapsulated form of ...

ST316, a β-catenin/BCL9 antagonist, demonstrated safety, target engagement, and early antitumor activity in advanced solid tumors.

The trial will focus on patients with Familial Adenomatous Polyposis (FAP), indicating the company is addressing urgent medical needs in a high-risk patient population. This initiative is ...

The planned Phase 2 study will evaluate the efficacy and safety of TPST-1495 in patients with Familial Adenomatous Polyposis (FAP) who have previously undergone colectomy. The primary efficacy ...

According to the World Health Organization (WHO), colorectal cancer is the third most common cancer worldwide, accounting for ...